Jardimet XR 25 mg+1000 mg (Tablet (Extended Release))
Unit Price: ৳ 45.00 (2 x 10: ৳ 900.00)
Strip Price: ৳ 450.00
Medicine Details
Category | Details |
---|---|
Generic | Empagliflozin metformin hydrochloride |
Company | Beximco pharmaceuticals ltd |
Also available as |
Indications
- Treatment of adults with type 2 diabetes mellitus
- Adjunct to diet and exercise
- Combination therapy for patients insufficiently controlled with Metformin
- Use in patients already being treated with the combination of Empagliflozin and Metformin separately
Pharmacology
- Empagliflozin is an inhibitor of SGLT2
- Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug
- Reduces renal reabsorption of filtered glucose
- Lowers renal threshold for glucose
- Decreases hepatic glucose production
- Decreases intestinal absorption of glucose
- Improves insulin sensitivity
Dosage & Administration
- Dosage should be individualized based on effectiveness and tolerability
- Take twice daily with meals
- Maximum recommended daily dose of Metformin Hydrochloride is 2000 mg and Empagliflozin is 25 mg
- Recommended individualized starting dose based on patient's current regimen
Interaction
- Diuretics
- Insulin or Insulin Secretagogues
- Positive Urine Glucose Test
- Drugs that Reduce Metformin Clearance
- Carbonic Anhydrase Inhibitors
- Drugs Affecting Glycemic Control
- Alcohol
Contraindications
- Hypersensitivity to Empagliflozin and Metformin
- Acute metabolic acidosis
- Diabetic pre-coma
- Severe renal failure
- Acute conditions with potential to alter renal function
- Disease causing tissue hypoxia
- Hepatic impairment
- Acute alcohol intoxication
- Alcoholism
Side Effects
- Urinary tract infection
- Female genital mycotic infections
- Diarrhea
- Nausea/vomiting
- Flatulence
- Abdominal discomfort
- Indigestion
- Asthenia
- Headache
- Hypoglycemia
- Vaginal moniliasis
- Urinary tract infection
- Volume depletion
- Urticaria
- Dysuria
- Lactic acidosis
Pregnancy & Lactation
- Potential risk to fetus
- Not recommended during breastfeeding
Precautions & Warnings
- Lactic Acidosis
- Hypotension
- Ketoacidosis
- Acute kidney injury & impairment in renal function
- Urosepsis, Pyelonephritis, Fournier’s gangrene & Genital mycotic infections
- Hypoglycemia
- Vitamin B12 Deficiency
- Increased LDL-C
- Macrovascular Outcomes
Overdose Effects
- Hypoglycemia with Empagliflozin doses
- Lactic acidosis with Metformin doses
- Treatment in a hospital setting
- Haemodialysis for removal of lactate and Metformin
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Below 30°C temperature
- Protected from light & moisture
Related Brands
- EmpaMet 12.5 mg+500 mg (Tablet) - nipro-jmi-pharma-ltd
- EmpaMet 5 mg+850 mg (Tablet) - nipro-jmi-pharma-ltd
- EmpaMet XR 5 mg+1000 mg (Tablet (Extended Release)) - nipro-jmi-pharma-ltd
- EmpaMet XR 10 mg+1000 mg (Tablet (Extended Release)) - nipro-jmi-pharma-ltd
- EmpaMet XR 25 mg+1000 mg (Tablet (Extended Release)) - nipro-jmi-pharma-ltd